Pharmaceutical giant Allergan has recently pleaded guilty and
agreed to pay a $600 million to settle charges that it aggressively
promoted off-label uses of the drug Botox that were not approved by
reports DrBicuspid.com. Off-label uses included treatment of
headache, pain and cerebral palsy in
Most of the settlement is in criminal fines.
However, Allergan will pay $225 million to a civil settlement
agreement with both federal and state governments that such
aggressive marketing resulted in federal and state insurance
programs Medicaid, Medicare and Tricare reimbursing false medical
As for how this affects dentistry, according to
DrBicuspid.com, use of Botox for dental procedures like retraining
muscles after orthodontic treatment and treatment of disorders like
bruxism and TMJ has surged in the US and UK in recent years.
However, Allergan may only promote Botox to health care providers
for limited medical procedures and treatment of lines between the
I have always been leary about the off-label use of Botox in dentistry. I have seen CE course for Botox in dentistry and am concerned about the training these 8 hr course really provide.
Posted by: Dr. J.B. Miller (firstname.lastname@example.org) on 05/16/2011